Filipini - angleščina - FDA (Food And Drug Administration)

n/a; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - paracetamol , guaifenesin hydrochloride , dextromethorphan hydrobromide , chlorphenamine maleate - capsule - formulation: each capsule contains: paracetamol-325mg guaifenesin-50mg phenylpropanolamine hydrochloride-12.5mg dextromethorphan hydrobromide-10mg chlorphenamine maleate-1mg

Irska - angleščina - HPRA (Health Products Regulatory Authority)

a.h. robins company limited - phenylephrine hydrochloride phenylpropanolamine hydrochloride brompheniramine maleate - tablets

Irska - angleščina - HPRA (Health Products Regulatory Authority)

a.h. robins company limited - phenylephrine hydrochloride phenylpropanolamine hydrochloride brompheniramine maleate - syrup

Malta - angleščina - Malta Medicines Authority

martindale pharmaceuticals limited bampton road, harold hill, romford essex, rm3 8ug, united kingdom - ephedrine hydrochloride - solution for injection - ephedrine hydrochloride 30 mg/ml - drugs for obstructive airway diseases

Kanada - angleščina - Health Canada

prodemdis enr. - phenylpropanolamine hydrochloride; chlorpheniramine maleate; pheniramine maleate - capsule (sustained-release) - 50mg; 1mg; 12.5mg - phenylpropanolamine hydrochloride 50mg; chlorpheniramine maleate 1mg; pheniramine maleate 12.5mg - propylamine derivatives

Kanada - angleščina - Health Canada

novartis consumer health canada inc. - phenylpropanolamine hydrochloride; pheniramine maleate; pyrilamine maleate - tablet (extended-release) - 50mg; 25mg; 25mg - phenylpropanolamine hydrochloride 50mg; pheniramine maleate 25mg; pyrilamine maleate 25mg - first generation antihistamines

Kanada - angleščina - Health Canada

whitehall-robins inc. - phenylpropanolamine hydrochloride; brompheniramine maleate - liquid - 12.5mg; 2mg - phenylpropanolamine hydrochloride 12.5mg; brompheniramine maleate 2mg - propylamine derivatives

Kanada - angleščina - Health Canada

whitehall-robins inc. - brompheniramine maleate; phenylpropanolamine hydrochloride - tablet - 1mg; 6.25mg - brompheniramine maleate 1mg; phenylpropanolamine hydrochloride 6.25mg - propylamine derivatives

Združene države Amerike - angleščina - NLM (National Library of Medicine)

state of florida doh central pharmacy - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin hydrochloride 1 mg - terazosin hydrochloride is indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin hydrochloride. the long-term effects of terazosin hydrochloride on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin hydrochloride is also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

rebel distributors corp - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin hydrochloride 2 mg - terazosin hydrochloride is indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin hydrochloride. the long-term effects of terazosin hydrochloride on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin hydrochloride is also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.